Pre-Implantation Methylation Multiple Screening (PIMS-Plus)
Product introduction
Pre-Implantation Methylation Multiple Screening (PIMS-Plus) can examine the copy number variation of chromosomes (CNV), DNA methylation information, monogenic disease and the variation of the chromosome structure with an upgraded self-developed single-cell genome methylation sequencing method, combined with artificial intelligence algorithm to screen the embryo developmental potential, select embryo for implantation, and thus promote the birth rates.
Product advantage
One screening covers multiple results
- genome methylation detection
- copy number variation of chromosomes (CNV) detection
- molecular genetic testing of chromosome
- epigenetic diseases detection
- prediction of embryo potential development
- monogenic disease detection
Service process
genetic counseling
identify the clinical indications
sample collection
6-8 trophoblast cell
sample transport
cold chain transport at -80°C
full range temperature monitoring
PIMS Plus detection
15 workdays
detection report
ranking of embryo for implantation
